Interestingly, we found c-MYC level and activity is directly regulated by PTEN expression and a significant overlap between hi-c-Myc and Pten null or mAKT1 prostate cancer models in their associated prostate cancer-associated TFAs. This evidence concerns the gene PTEN and prostate carcinoma.